5-chloro-3-[(2-methylpropyl)sulfanyl]-1,2,4-thiadiazole, 95.0%, 1g

1-Acetyl-2,3-dihydropyrrolo(2,3-b)pyridine, 97%, 50mg

(2R,3R)-3-(Ethoxycarbonyl)oxirane-2-carboxylic acid, 98%, 1g

ETHOSUXIMIDE, 95%, 250mg

[5-(3-Methoxy-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-carbamic acid tert-butyl ester, 95.0%, 1g

2-(Methylamino)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinonitrile, 95.0%, 5g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 60, 100 ml, 90 mm, 1 Piece

4-(4-Nitrophenoxy)aniline, 98.0%, 250mg

7-TRIDECANOL, 95%, 25g

3,6-Dimethyl-1,4-dioxane-2,5-dione, 99.0%, 500g

3-Methoxy-5-(trifluoromethyl)benzylamine, 1g

(3aR,4S,7aR)-4-(m-tolylethynyl)octahydro-1H-indol-4-ol hydrochloride, 98%, 100mg

4-(2-Methoxyphenyl)butanoic acid, 95%, 500mg